FREMONT, CA, Nov. 14, 2022 (GLOBE NEWSWIRE) via NewMediaWire - ABVC BioPharma, Inc. (Nasdaq: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology
ABVC BioPharma (ABVC) Announces Vitargus Phase II Study Plan Approved by HREC in Australia streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
ABVC BioPharma, Inc (ABVC) Provides Vitargus Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
ABVC BioPharma Reports Second Quarter 2022 Financial and Operational Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.